New Anti-inflammatory Treatment Strategy in Alzheimer's Disease

この論文にアクセスする

この論文をさがす

著者

    • Uz Tolga UZ Tolga
    • The Psychiatric Institute, West Side VA Medical Center, Department of Psychiatry, University of Illinois at Chicago
    • MANEV Hari
    • The Psychiatric Institute, West Side VA Medical Center, Department of Psychiatry, University of Illinois at Chicago

抄録

Numerous reports have indicated that patients suffering from inflammatory diseases(e.g., arthritis)who take anti-inflammatory medication have a reduced risk of developing Alzheimer’s disease(AD).Thus, the first generation of anti-inflammatory cyclooxygenase(COX)inhibitors, such as aspirin and indomethacin, have been tested as potential therapeutics in AD.Because the inhibition of COX-1 is also known to cause tissue damage in the gastrointestinal system from the resultant reduced cytoprotection, selective COX-2 inhibitors are being investigated and tested clinically as potentially better therapeutics for AD patients.However, such drugs may also trigger unwanted effects;for example, the COX-2 inhibitors, which reduce the production of one type of eicosanoids, the prostaglandins, may increase the production of other eicosanoids;i.e., the leukotriene B<SUB>4</SUB>(LTB<SUB>4</SUB>), which is one of the most potent endogenous chemotactic/inflammatory factors.LTB<SUB>4</SUB> production is initiated by the enzyme 5-lipoxygenase(5-LOX).The expression of the 5-LOX gene is upregulated during neurodegeneration and with aging.In spite of the fact that 5-LOX and leukotrienes are major players in the inflammation cascade, their role in AD pathobiology/therapy has not been extensively investigated.We propose that the 5-LOX inflammatory cascade may take part in the process of aging-associated neurodegenerative diseases, and we point to the role of 5-LOX in neurodegeneration and discuss its relevance for anti-inflammatory therapy of AD.

収録刊行物

  • The Japanese journal of pharmacology

    The Japanese journal of pharmacology 82(2), 85-94, 2000-02-01

    公益社団法人 日本薬理学会

参考文献:  109件中 1-100件 を表示

  • 1 / 2
  • 1 / 2

被引用文献:  1件中 1-1件 を表示

各種コード

  • NII論文ID(NAID)
    10008182822
  • NII書誌ID(NCID)
    AA00691188
  • 本文言語コード
    ENG
  • 資料種別
    REV
  • ISSN
    00215198
  • NDL 記事登録ID
    5283857
  • NDL 雑誌分類
    ZS51(科学技術--薬学)
  • NDL 請求記号
    Z53-D199
  • データ提供元
    CJP書誌  CJP引用  NDL  J-STAGE 
ページトップへ